News | September 12, 2022
Zenara Pharma launches the first generic of Paxlovid for COVID-19 in India
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
Aimed at improving patient outcomes and increasing connectivity for more efficient monitoring In hospitals and homes
NCDC branches in States/UTs will provide a boost to Public Health Infrastructurewith prompt surveillance, rapid detection and timely monitoring of diseases enabling Early Interventions
Proceeds from the proposed issue will be utilized to part finance Balaxi’s planned EU GMP-compliant manufacturing facility for Oral Solid Dosages and Liquid Injectables at TSIIC Pharma Formulations SEZ
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Chlorthalidone Tablets USP, 25 mg and 50 mg, have an estimated market size of US $37 million for twelve months ending June, 2022 according to IQVIA
he approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Hygroton Tablets, 25 mg and 50 mg, of Sanofi Aventis US. LLC (Sanofi).
Sandoz is planned to be incorporated in Switzerland and to be listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in the US
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
Subscribe To Our Newsletter & Stay Updated
